• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[基质金属蛋白酶-2、9及其组织抑制剂-1、2在子宫内膜癌中的表达]

[Expression of matrix metalloproteinase-2, 9 and it's tissue inhibitor-1, 2 in endometrial carcinoma].

作者信息

Guo Wenping, Chen Guian, Zhu Cheng, Wang Hongmei

机构信息

Department of Obstetrics and Gynecology, the Third Hospital, Peking University, Beijing 100083, China.

出版信息

Zhonghua Fu Chan Ke Za Zhi. 2002 Oct;37(10):604-7.

PMID:12487935
Abstract

OBJECTIVE

To study the expression of matrix metalloproteinase (MMP)-2, 9 and tissue inhibitor of metalloproteinase (TIMP)-1, 2 protein in human endometrial carcinoma tissue and its relation to the invasion and metastasis of endometrial carcinoma.

METHODS

Immunocytochemistry and zymography techniques were used to measure the MMP-2, MMP-9, TIMP-1, TIMP-2 protein levels and activities in endometrial carcinoma tissue of 37 patients and control group composed of 7 normal postmenstrual endometrial samples.

RESULTS

The MMP-2, MMP-9, TIMP-1 and TIMP-2 proteins mainly expressed in endometrial carcinoma cells, glandular cells and endothelial cells. The strongly positive expression proportions of MMP-2, 9 and TIMP-1 proteins in grade III carcinoma cells were respectively 73%, 20% and 67%, which were higher than those in grade II (13%, 0, 27%) and grade I (0) ones (P < 0.05). They were also higher in endometrial carcinoma with deep layer invasion ones (63%, 16%, 68%) and lymph node metastasis ones (4/4, 3/4, 4/4). TIMP-2 did not show different expression with the tumor invasion and metastasis. In endothelial cells of grade III carcinoma tissue the strongly positive expression proportions of MMP-2 (60%) and TIMP-1 (60%) proteins, not MMP-9, were found in higher amount comparing with those in grade II (20%) and grade I (1/7) tumor tissues (P < 0.05). The density of above four proteins were all found very low in the normal postmenopausal endometrial tissues (P < 0.05). By zymography test the active MMP-2 was the main protein form in adenocarcinoma tissue.

CONCLUSIONS

MMP-2 and MMP-9 expression levels in adenocarcinoma tissue correlate with the histologic grade and invasion/metastasis trend. Active MMP-2 is the main form in endometrial cancer.

摘要

目的

研究基质金属蛋白酶(MMP)-2、9及金属蛋白酶组织抑制剂(TIMP)-1、2蛋白在人子宫内膜癌组织中的表达及其与子宫内膜癌侵袭和转移的关系。

方法

采用免疫细胞化学和酶谱分析技术,检测37例子宫内膜癌患者癌组织及由7例正常绝经后子宫内膜样本组成的对照组中MMP-2、MMP-9、TIMP-1、TIMP-2蛋白水平及活性。

结果

MMP-2、MMP-9、TIMP-1和TIMP-2蛋白主要表达于子宫内膜癌细胞、腺上皮细胞及内皮细胞。MMP-2、9及TIMP-1蛋白在Ⅲ级癌细胞中的强阳性表达率分别为73%、20%和67%,高于Ⅱ级(13%、0、27%)和Ⅰ级(0)(P<0.05)。在深层浸润的子宫内膜癌(63%、16%、68%)及有淋巴结转移的病例(4/4、3/4、4/4)中其表达也较高。TIMP-2的表达与肿瘤侵袭和转移无关。Ⅲ级癌组织内皮细胞中MMP-2(60%)和TIMP-1(60%)蛋白的强阳性表达率高于Ⅱ级(20%)和Ⅰ级(1/7)肿瘤组织(P<0.05),MMP-9则未发现此差异。在正常绝经后子宫内膜组织中上述4种蛋白的表达均很低(P<0.05)。酶谱分析显示,活性MMP-2是腺癌组织中的主要蛋白形式。

结论

腺癌组织中MMP-2和MMP-9的表达水平与组织学分级及侵袭/转移趋势相关。活性MMP-2是子宫内膜癌中的主要形式。

相似文献

1
[Expression of matrix metalloproteinase-2, 9 and it's tissue inhibitor-1, 2 in endometrial carcinoma].[基质金属蛋白酶-2、9及其组织抑制剂-1、2在子宫内膜癌中的表达]
Zhonghua Fu Chan Ke Za Zhi. 2002 Oct;37(10):604-7.
2
Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in uterine endometrial carcinoma and a correlation between expression of matrix metalloproteinase-7 and prognosis.基质金属蛋白酶及其组织抑制剂在子宫内膜癌中的表达以及基质金属蛋白酶-7表达与预后的相关性
Int J Mol Med. 2005 Oct;16(4):541-6.
3
[Expression of matrix metaloproteinase and tissue inhibitors in ovarian tumors].[基质金属蛋白酶及组织抑制剂在卵巢肿瘤中的表达]
Ai Zheng. 2002 Jan;21(1):91-4.
4
[Expression of matrix metalloproteinase-2, 9 and their inhibitor-TIMP 1,2 in human squamous cell carcinoma of uterine cervix].[基质金属蛋白酶-2、9及其抑制剂-基质金属蛋白酶组织抑制因子1、2在子宫颈鳞状细胞癌中的表达]
Ai Zheng. 2002 Jul;21(7):735-9.
5
Immunohistochemical detection of matrix metalloproteinases (MMP) 1 and 2, and tissue inhibitor of metalloproteinase 2 (TIMP 2) in stage I and II endometrial cancer.Ⅰ期和Ⅱ期子宫内膜癌中基质金属蛋白酶(MMP)1和2以及金属蛋白酶组织抑制剂2(TIMP 2)的免疫组织化学检测
Anticancer Res. 1999 May-Jun;19(3B):2365-7.
6
[Relationship of expression unbalance of matrix metalloproteinase and tissue inhibitor of metalloproteinase to invasiveness and metastasis in gastric carcinomas].基质金属蛋白酶与金属蛋白酶组织抑制剂表达失衡与胃癌侵袭和转移的关系
Ai Zheng. 2002 Mar;21(3):305-10.
7
[Assay of matrix metalloproteinase levels and their endogenous inhibitors in patients with laryngeal carcinoma].[喉癌患者基质金属蛋白酶水平及其内源性抑制剂的检测]
Vopr Onkol. 2007;53(1):26-31.
8
Significance of matrix metalloproteinases and tissue inhibitors of metalloproteinase expression in the recurrence of superficial transitional cell carcinoma of the bladder.基质金属蛋白酶及金属蛋白酶组织抑制剂表达在膀胱浅表性移行细胞癌复发中的意义
J Urol. 2001 May;165(5):1769-72.
9
Significance of matrix metalloproteinase-7 [correction of matrix metalloproteinase-2], -11 and tissue inhibitor of metalloproteinase-1 expression in normal, hyperplastic and neoplastic endometrium.基质金属蛋白酶-7[校正为基质金属蛋白酶-2]、-11及金属蛋白酶组织抑制剂-1在正常、增生及肿瘤性子宫内膜中表达的意义
Anticancer Res. 2007 Jan-Feb;27(1A):95-105.
10
Significant relationship of matrix metalloproteinase 9 with nuclear grade and prognostic impact of tissue inhibitor of metalloproteinase 2 for incidental clear cell renal cell carcinoma.基质金属蛋白酶9与核分级的显著关系以及金属蛋白酶组织抑制剂2对偶然发现的透明细胞肾细胞癌的预后影响
Urology. 2007 Jun;69(6):1049-53. doi: 10.1016/j.urology.2007.02.044.

引用本文的文献

1
Expression of laminin-1 and matrix metalloproteinase-9 in benign and malignant endometrium.层粘连蛋白-1 和基质金属蛋白酶-9 在良性和恶性子宫内膜中的表达。
Turk J Med Sci. 2023 Feb;53(1):149-159. doi: 10.55730/1300-0144.5568. Epub 2023 Feb 22.
2
Metalloproteinases in Endometrial Cancer-Are They Worth Measuring?金属蛋白酶在子宫内膜癌中的作用——它们值得测量吗?
Int J Mol Sci. 2021 Nov 19;22(22):12472. doi: 10.3390/ijms222212472.
3
Overexpression of the matrix metalloproteinase 11 gene is a potential biomarker for type 1 endometrial cancer.
基质金属蛋白酶11基因的过表达是I型子宫内膜癌的一个潜在生物标志物。
Oncol Lett. 2018 Jul;16(1):1073-1078. doi: 10.3892/ol.2018.8714. Epub 2018 May 16.
4
Clinical importance of serum HE4 and MMP2 levels in endometrial cancer patients.血清HE4和MMP2水平在子宫内膜癌患者中的临床意义。
Onco Targets Ther. 2017 Jun 27;10:3169-3175. doi: 10.2147/OTT.S136750. eCollection 2017.
5
MicroRNA-200b is overexpressed in endometrial adenocarcinomas and enhances MMP2 activity by downregulating TIMP2 in human endometrial cancer cell line HEC-1A cells.微小 RNA-200b 在子宫内膜腺癌中过表达,并通过下调人子宫内膜癌细胞系 HEC-1A 细胞中的 TIMP2 来增强 MMP2 活性。
Nucleic Acid Ther. 2013 Feb;23(1):29-34. doi: 10.1089/nat.2012.0385. Epub 2012 Dec 3.
6
Autocrine human growth hormone stimulates oncogenicity of endometrial carcinoma cells.自分泌人生长激素刺激子宫内膜癌细胞的致癌性。
Endocrinology. 2008 Aug;149(8):3909-19. doi: 10.1210/en.2008-0286. Epub 2008 May 1.
7
Correlative studies on bFGF mRNA and MMP-9 mRNA expressions with microvascular density, progression, and prognosis of gastric carcinomas.碱性成纤维细胞生长因子mRNA和基质金属蛋白酶-9 mRNA表达与胃癌微血管密度、进展及预后的相关性研究
World J Gastroenterol. 2005 Jun 7;11(21):3227-33. doi: 10.3748/wjg.v11.i21.3227.